K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.

BACKGROUND The K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease was published in October 2003. The objective of this study was to analyse the effect of the application of those guidelines on clinical practices and on the achievement of bone disease targets and quality standards. METHODS We included in the study 342 patients dialysed in our three HD...

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.

BACKGROUND The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predominantly based on studies in haemodialysis (HD) patients. However, in clinical practice, this guideline is also applied to peritoneal dialysis (PD) patients. To validate the implementation of this guideline in PD patients, we evaluated the associations between plasma concentrations outside the K/DO...

Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.

BACKGROUND Abnormalities in mineral metabolism in chronic kidney disease are associated with increased morbidity and mortality. The Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines were established in 2003 to address issues in the management of mineral and bone metabolism. The goal of this study was to compare (i) mineral metabolism control among Canadian haemodi...

Survival benefit with regional anticoagulation with citrate in CRRT: the end of a myth?

of K/DOQI targets of mineral metabolism in Canada. Nephrol Dial Transplant 2011; 26: 156–163 6. Block GA, Zaun D, Smits G et al. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int 2010; 78: 578–589 7. Vervloet M, Bencova V, Malberti F et al. “Real-world” use of cinacalcet for managing SHPT in dif...

NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation.